{"id":829,"date":"2021-06-11T12:21:52","date_gmt":"2021-06-11T19:21:52","guid":{"rendered":"https:\/\/staff.washington.edu\/jbleys\/wordpress\/?page_id=829"},"modified":"2021-06-11T12:21:52","modified_gmt":"2021-06-11T19:21:52","slug":"enterics-for-global-health","status":"publish","type":"page","link":"https:\/\/staff.washington.edu\/jbleys\/wordpress\/enterics-for-global-health\/","title":{"rendered":"Enterics For Global Health"},"content":{"rendered":"

The Enterics for Global Health<\/a> (EFGH) Shigella surveillance study will employ cross-sectional and longitudinal study designs to establish incidence and consequences of Shigella moderate-to-severe diarrhea within 7 country sites in Africa, Asia, and Latin America. Through this multi-country surveillance network and associated clinical and laboratory standardization and capacity building, selected EFGH sites will be ready to quickly implement rigorous and efficient vaccine trials, accelerating the time to vaccine availability to children in low- and middle-income countries.<\/p>\n

Header one<\/h1>\n

Header two<\/h2>\n

Header three<\/h3>\n

Header four<\/h4>\n

Header five<\/h5>\n
Header six<\/h6>\n

Larger Button<\/a>
\nSmaller Button<\/a><\/p>\n

\n

Morbi leo risus, porta ac consectetur ac, vestibulum at eros. Etiam porta sem malesuada magna mollis euismod. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Nullam quis risus eget urna mollis ornare vel eu leo. Donec sed odio dui.<\/p>\n<\/blockquote>\n\n\n\n\n\n\n\n\n
Ornare<\/th>\nEtiam<\/th>\n<\/th>\n<\/tr>\n<\/thead>\n
Auit Manro<\/td>\n1<\/td>\nVestibulum id ligula porta felis euismod semper.<\/td>\n<\/tr>\n
Purus Ligula<\/td>\n100<\/td>\nCras justo odio, dapibus ac facilisis in, egestas eget quam.<\/td>\n<\/tr>\n
Etiam Mollis<\/td>\n1,000<\/td>\nCum sociis natoque penatibus et magnis dis parturient montes, nascetur.<\/td>\n<\/tr>\n
Ipsum Parturient<\/td>\n10.01<\/td>\nSed posuere consectetur est at lobortis.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n